4D Molecular Therapeutics, Inc.

FDMT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$11.89-6.92%

2026-10-30

Financials

Valuation Metrics

4D Molecular Therapeutics, Inc.'s Market Cap is $622M. At end of 2025 it was $434M. Ranked #2655 of 3,118 in US market (top 85%), #1141 of 1,474 on NASDAQ (top 77%), #204 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 77%) by Market Cap.

Investment Metrics(as of 2026-10-30)

Metric	Value	Rank
Size
Market Cap	$622M	US#2,655/3,118 Sec#204/265
Revenue	$92M	US#2,687/3,118 Sec#127/265
Net Income	$-179M	US—/3,118 Sec—/265
Total Assets	$493M	US#2,765/3,118 Sec#165/265
Net Assets	$408M	US#2,353/3,118 Sec#133/265
Value
P/B	1.53x	US#922/3,118 Sec#39/265
P/S	6.76x	US#2,519/3,118 Sec#96/265
FCF Yield	-25.19%	US—/3,118 Sec—/265
Profitability
ROE	-43.95%	US#2,646/3,118 Sec#145/265
ROA	-36.37%	US#2,921/3,118 Sec#179/265
Op. Margin	-214.24%	US#2,747/3,118 Sec#137/265
Revenue Growth	278712.12%	US#1/3,118 Sec#1/265
Financial Health
Debt Ratio	20.84%	US#234/3,118 Sec#78/265
Total Debt	$39M	US#2,636/3,118 Sec#162/265
FCF	$-157M	US#2,722/3,118 Sec#183/265
Cash	$70M	US#2,422/3,118 Sec#202/265
Current Ratio	8.03x	US#310/3,118 Sec#96/265
Performance
1Y Return	5.08%	US#1,652/3,118 Sec#138/265
1M Return	-16.88%	US#2,717/3,118 Sec#214/265
From 52W High	-29.74%	US#1,928/3,118 Sec#120/265
1Y MDD	-38.34%	US#1,839/3,118 Sec#107/265
Trading
Volume	528,986 shares	US#2,009/3,118 Sec#198/265
Trading Value	$6M	US#2,507/3,118 Sec#194/265
Per Share
EPS	$-3.43	US—/3,118 Sec—/265
BPS	$7.80	US#2,013/3,118 Sec#89/265